Venus Remedies awarded its first incentive of Rs.7.50 crore under PLl scheme
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
ANVISA issues CGMP to Concord Biotech’s Unit I
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
The Convocation ceremony was organized for students skilled and certified in Ayush
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
Launch of Indian public health standards for Ayush healthcare facilities
Cipla completes transfer of Generics Business Undertaking
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
The product will be launched in March 2024
Subscribe To Our Newsletter & Stay Updated